To investigate the clinical relevance of PRKCI signaling in human pancreatic cancer, we assessed the association of PRKCI expression, PRKCI copy number, and signaling activity with PDAC tumor characteristics and patient outcomes. The gene discussed is PRKCI; the disease is pancreatic neoplasm.